Featured Research

from universities, journals, and other organizations

Key Mechanism In Development Of Nerve Cells Found

Date:
September 30, 2009
Source:
University of Helsinki
Summary:
Chaos brews in the brains of newborns: the nerve cells are still bound only loosely to each other. Researchers have been studying how a neural network capable of processing information effectively is created out of chaos. A team in Finland has now found a new kind of mechanism that adjusts the functional development of nerve cell contacts.

Chaos brews in the brains of newborns: the nerve cells are still bound only loosely to each other. Under the leadership of Academy Research Fellow Sari Lauri, a team of researchers at the University of Helsinki has been studying for years how a neural network capable of processing information effectively is created out of chaos. The team has now found a new kind of mechanism that adjusts the functional development of nerve cell contacts.

The results were published in early September as the leading article of the Journal of Neuroscience.

The work carried out by Lauri's team and its partners at the Viikki campus sheds light on a development path that results in some of the large number of early synapses becoming stronger. The researchers found out hat the BDNF growth factor of nerve cells triggers a functional chain which promotes the release of the neurotransmitter glutamate. BDNF enables the release of glutamate by prohibiting the function of kainate receptors which slow down the development of the preforms of the synapses. The activity of the kainate receptors restricts the release of glutamate and the development of synapses into functional nerve cell contacts.

It is noteworthy that the brain of a newborn itself seems to organise its own development. The electrical activity of the waking brain triggers the series of events controlled by the BDNF protein, as a result of which kainate receptor activity disappears in some synapses. The development is based on the considerable plasticity of the developing neural network: it can reshape its structureand function to a large extent.

According to Lauri, the new research results help understand how central nervous system diseases originating in early development are established. The finding also provides researchers with the opportunity to obtain information about the different aspects of endogenous activity of the brain. At the same time, it could be possible to develop new kinds of pharmaceuticals for the treatment of childhood epilepsy, for example.

Lauri's team conducted the research in co-operation with the research teams of Eero Castren and Tomi Taira from the Neuroscience Centre, and the research team of Jari Yli-Kauhaluoma from the Faculty of Pharmacy.


Story Source:

The above story is based on materials provided by University of Helsinki. Note: Materials may be edited for content and length.


Cite This Page:

University of Helsinki. "Key Mechanism In Development Of Nerve Cells Found." ScienceDaily. ScienceDaily, 30 September 2009. <www.sciencedaily.com/releases/2009/09/090929132507.htm>.
University of Helsinki. (2009, September 30). Key Mechanism In Development Of Nerve Cells Found. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/09/090929132507.htm
University of Helsinki. "Key Mechanism In Development Of Nerve Cells Found." ScienceDaily. www.sciencedaily.com/releases/2009/09/090929132507.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins